Experiment 852369

Worktypes

ANTICANCER AND/OR CYTOTOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN HUMANSPATENT DESCRIBED

Compounds isolated

DIOSGENIN-3-O-ALPHA-L-RHAMNOPYRANOSYL-(1-4)-ALPHA-L-RHAMNOPYRANOSYL-(1-4)-(ALPHA-L-RHAMNOPYRANOSYL-(1-2))-BETA-D-GLUCOPYRANOSIDE

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeORAL
OrganismEmpty organism
CitationKOSUGE,S:. (1985). ANTITUMOR FORMULATIONS CONTAINING DIOSGENIN GLYCOSIDES.. ()
Amount utilized
Compound isolated
DiseaseUSED TO TREAT CANCER.
Dose amount300.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitPERSON
Dose expressionDOSE